<p>How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.</p>

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.

<p>How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few &amp; Far Between podcast, host Marc Gas, PhD, welcomes Kelly Franchetti, RN, SVP at YPrime, to discuss where advocacy is headed and where it needs to go.</p>

Episode 13:  Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Science

Medicine

Health & Fitness

Mental Health

Life Sciences

Welcome to Few &amp; Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.

Share Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

Sign up to save your podcasts

Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

More shows like Few & Far Between: Conversations from the Front Lines of Drug Development

The Readout Loud